22 completed, 14 unknown, 5 recruiting, 4 not yet recruiting. 18 Phase 1, 12 Phase 4, 9 Phase 3, 6 Not applicable, 3 Phase 2.
Follow tegoprazan: new trials by email Literature Review of tegoprazan trials Research Report on tegoprazan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tegoprazan-Aspirin Drug Interaction in Healthy Adult Male Volunteers Aspirin, Tegoprazan, Tegoprazan + Aspirin - Healthy Adult Male | Phase 1 | Not yet recruiting | HK inno.N Corporation | 34 | 2026-10-14 | 2026-10-01 |
| A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERD Tegoprazan 50 mg, Placebo - GERD (Gastroesophageal Reflux Disease) | Phase 4 | Not yet recruiting | HK inno.N Corporation | 100 | 2026-09-01 | 2026-09-17 |
| Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic Ulcers Tegoprazan tablet, Lansoprazole capsules - Peptic Ulcer Bleeding | Phase 2 | Recruiting | Universitas Indonesia | 162 | 2026-08-06 | 2026-08-21 |
| Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) Tegoprazan 50 mg, Placebo - Ischemic Stroke, Ischemic Stroke, Acute | Phase 3 | Recruiting | Hanyang University Guri Hospital | 1524 | 2026-01-26 | 2026-07-08 |
| A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers Tegoprazan, Naproxen, IN-M00002 - Healthy Volunteer | Phase 1 | Not yet recruiting | HK inno.N Corporation | 74 | 2025-12-27 | 2025-12-11 |
| Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication（Frequency Adjusted Same-dose Therapy for H. Pylori） Tegoprazan 50 mg, Amoxicillin 1 g TID, Amoxicillin 1.5 g BID - HELICOBACTER PYLORI INFECTIONS | Phase 4 | Not yet recruiting | First People's Hospital of Hangzhou | 240 | 2025-11-20 | 2025-11-21 |
| Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia Tegoprazan, Famotidine, Placebo - General Anesthesia | Phase 4 | Enrolling by invitation | Seok Kyeong Oh | 174 | 2025-07-23 | 2025-09-05 |
| Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial Tegoprazan, Amoxicillin, Tetracycline - Helicobacter Pylori Eradication, Adverse Reaction | Not applicable | Completed | Zhongshan Hospital (Xiamen), Fudan University | 640 | 2025-06-10 | 2026-05-19 |
| Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment Tegoprazan, Lansoprazole - Peptic Ulcer Bleeding | Not applicable | Recruiting | Mario Steffanus | 162 | 2025-05-01 | 2025-05-29 |
| Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication Tegoprazan, Amoxicillin, Vonoprazan - Helicobacter Pylori Infection | Phase 2 / Phase 3 | Recruiting | First People's Hospital of Hangzhou | 240 | 2025-02-17 | 2025-11-21 |
| Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment tegoprazan, Minocycline, bismuth potassium citrate - Helicobacter Pylori Infection Chronic Gastrit | Phase 4 | Active not recruiting | Xijing Hospital of Digestive Diseases | 208 | 2024-11-11 | 2025-07-03 |
| A Phase I Study of LX22001 for Injection in Healthy Subjects LX22001 for Injeciton, Tegoprazan tablet, Esomeprazole sodium for injection - Healthy | Phase 1 | Unknown | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 70 | 2024-08-05 | 2024-08-20 |
| Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole Tegoprazan, Pantoprazole - Gastroesophageal Reflux Disease | Phase 4 | Recruiting | Carnot Laboratories | 128 | 2024-07-30 | 2025-07-23 |
| Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole Tegoprazan, Esomeprazole 40mg - Helicobacter Pylori Infection | Phase 4 | Unknown | Hospital General de México Dr. Eduardo Liceaga | 160 | 2024-04-19 | 2024-03-19 |
| PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects Tegoprazan 12.5mg, Tegoprazan 25mg, Famotidine 20mg - Healthy | Phase 1 | Unknown | HK inno.N Corporation | 36 | 2024-03-19 | 2024-03-27 |
| Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects Clopidogrel 75 mg, Tegoprazan 25 mg, Esomeprazole 20mg - Healthy | Phase 1 | Unknown | HK inno.N Corporation | 48 | 2023-12-05 | 2023-12-11 |
| Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1) Tegoprazan 50 mg, tablets, orally, qd, Esomeprazole 20mg BID, Tegoprazan 50 mg, tablets, orally, bid - Helicobacter Pylori Infection | Phase 4 | Completed | Zhang Xiaofeng,MD | 370 | 2023-11-01 | 2026-01-16 |
| Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori（SHARE2302) 7days bismuth quadruple, 14 days bismuth quadruple - Helicobacter Pylori Infection | Not applicable | Unknown | Shandong University | 254 | 2023-09-02 | 2024-01-11 |
| Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301） Tegoprazan, Amoxicillin, Esomeprazole - Helicobacter Pylori Infection | Not applicable | Unknown | Yanqing Li | 368 | 2023-05-24 | 2023-07-11 |
| A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn Tegoprazan, Esomeprazole - Gastroesophageal Reflux Disease | Phase 4 | Unknown | HK inno.N Corporation | 338 | 2023-03-24 | 2023-08-03 |
Showing 20 of 48. Sign in to see all of them.
Gastroesophageal Reflux (4) · Peptic Ulcer Hemorrhage (2) · Cerebrovascular Disorders (1) · Dyspepsia (1) · Gastrointestinal Hemorrhage (1) · Ischemic Attack, Transient (1) · Ischemic Stroke (1) · Peptic Ulcer (1)
HK inno.N Corporation (25) · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (3) · Shandong University (3) · First People's Hospital of Hangzhou (2) · Asan Medical Center (1) · Carnot Laboratories (1) · Hanyang University Guri Hospital (1) · Hospital General de México Dr. Eduardo Liceaga (1) · Incheon St.Mary's Hospital (1) · Mario Steffanus (1) · Pusan National University Hospital (1) · Seok Kyeong Oh (1) · Seoul National University Bundang Hospital (1) · Seoul National University Hospital (1) · Universitas Indonesia (1)
South Korea (30) · China (12) · Indonesia (2) · Mexico (1)
In-Jin Jang, MD, PhD (2) · Sang Kil Lee, Ph.D (2) · Do Hoon Kim (1) · Dong-Seong Shin, MD, PhD (1) · Eon-Hye Kim, MD, PhD (1) · Hasan Maulahela, MD, PhD (1) · Hongyun Wang (1) · Hongzhong Liu (1) · Hwoon Yong Jung, Professor (1) · In Jin Jang, MD, PhD (1) · In-Jin Jang (1) · Jae Gyu Kim (1) · Jea Jun Kim (1) · Jong Lyul Ghim, MD, PhD (1)
PMID 17170018, PMID 27707777, PMID 28456631, PMID 33004546, PMID 33637332, PMID 33691344, PMID 34836916, PMID 35787943, PMID 35956057, PMID 35979311, PMID 36690433, PMID 36897544, PMID 37834761, PMID 38853394, PMID 39587796, PMID 39932678, PMID 40272011, PMID 40462641, PMID 40846665, PMID 41531249, PMID 42277990, PMID 42325011, PMID 42829447